DIABETES MELLITUS IN MALAYSIA
This bibliography is a collection of Malaysian research/publications on diabetes mellitus. The search method follows the method that has been previously described.[1] In brief, clinical research publications containing data on Malaysia for the period 2000-2014 were included (last search date 28 Dec 2014). We have included conference proceedings (but not conference abstracts), relevant theses/dissertation, books/book chapters, reports and clinical practice guidelines. Where available, link to free full text is provided.
In view of the large number of items (n=679), this bibliography is divided into the seven parts. 1. Diabetes mellitus, type 2 [Mesh term: Diabetes Mellitus, Type 2]
2. Diabetes mellitus, type 1 [Mesh term: Diabetes Mellitus, Type 1]
3. Gestational diabetes and diabetes in pregnancy [Mesh term: Diabetes, Gestational] 4. Diabetic nephropathy [Mesh term: Diabetic Nephropathies]
5. Diabetic neuropathy [Mesh term: Diabetic Neuropathies] 6. Diabetic retinopathy [Mesh term: Diabetic Retinopathy] 7. Diabetic foot [Mesh term: Diabetic Foot]
The preparation of this bibliography is funded by a grant from National Clinical Research Centre to International Medical University (Project ID No. IMU R 150/2014). The project leader is Professor CL Teng. Searchers were made by CL Teng, Zuhanariah Mohd Nordin, Goh Cheng Chun and Ng Chun Sien. Kindly send enquiry about this
bibliography to tengcl@gmail.com
Reference:
1.
Teng CL, Zuhanariah MN, Ng CS, et al. Bibliography of clinical research in Malaysia: methods and brief results. Med J Malaysia 2014;69 Suppl A:4-7http://www.e-mjm.org/2014/supplement-A/bibliography-of-clinical-research-in-Malaysia.pdf.
PART 1: DIABETES MELLITUS, TYPE 2
Books, Book Chapters, Guidelines, Reports, Proceedings
1.
Abdol Malek AA, Mohamed Mansor M, Salmah B, et al. Drug Utilization in the Treatment of Diabetes Mellitus in the Ministry of Health Facilities. Kuala Lumpur: Ministry of Health, Malaysia, 2013http://www.pharmacy.gov.my/v2/sites/default/files/document-upload/drug-utilization-treatment-diabetes-mellitus-moh-malaysia.pdf
2.
Abida Haq, Syed M. Haq, Nurul Adha O, Tengku Malini, Tengku Mohamed Noor Izam, Ratna Suny ME. Protocol Medication Therapy Adherence Clinic: Diabetes. Kuala Lumpur: Ministry of Health, Malaysia, 2010http://www.pharmacy.gov.my/v2/sites/default/files/document-upload/drug-utilization-treatment-diabetes-mellitus-moh-malaysia.pdf
3. Annual Report of the Diabetes in Children & Adolescent Registry (DiCARE) 2006-2007. Kuala Lumpur: Ministry of Health, 2008
4.
Clinical Practice Guidelines: Management of Type 2 Diabetes Mellitus, Fourth Edition. Kuala Lumpur: Ministry of Health, Malaysia, 2009. http://www.acadmed.org.my/view_file.cfm?fileid=2925. Diabetes Registry Malaysia: report of an audit of diabetes control and management (January-December 2009). Kuala Lumpur: Clinical Research Centre, 2010
6. Feisul Idzwan M, Fatanah I, Nor Azlina AR. The burden of diabetes mellitus and its related complications in government hospitals in Malaysia (1999-2004). Putrajaya: Ministry of Health, Malaysia, 2007
7.
Health technology assessment report: Management of diabetes melitus and screening for microalbuminuria in diabetics. Kuala Lumpur: Ministry of Health, Malaysia, 20048. Medical Nutrition Therapy Guideline for Type 2 Diabetes, Second Edition. Malaysian Dietitians' Association, 2013
9. National Diabetes Registry Report, Volume 1 2009-2012. Ministry of Health, Malaysia, 2013
10.
Noormah MD, Roza S. Health technology assessment report: Nutritional therapy as a complement for diabetes and hypertension. Kuala Lumpur: Ministry of Health, Malaysia, 2013http://www.moh.gov.my/hta/Nutritional_Therapy_report.pdf
11. Practical Guide to Insulin Therapy in Type 2 Diabetes Mellitus. Ministry of Health, Malaysia, 2011
12. User Manual: Diabetes clinical audit in health facilities. [Manual pengguna. Audit klinikal diabetes di fasiliti kesihatan]. Kuala Lumpur: Ministry of Health, Malaysia, 2008
13. Wan Mohamad WB, Mastura I. Preliminary report of an audit of diabetes control and management (DRM-ADCM) July to December 2008. Kuala Lumpur: Diabetes Registry Malaysia, 2009
14. Wan Mohamad WB. Diabetes in Malaysia: Complications and Treatment. [Diabetes di Malaysia: Komplikasi dan Rawatan]. Pulau Pinang: Penerbit Universiti Sains Malaysia, 2005
Dissertations, Theses
1. Abdul Majeed SAR. Evaluation of coronary heart disease risk among patients with type 2 diabetes in Hospital Pulau Pinang, Malaysia. MSc Dissertation, Universiti Sains Malaysia, 2011.
2. Abdul Rahman H. Body mass index and its associated morbidity among elderly patients attending Klinik Kesihatan Parit Jawa, Muar. Dissertation, Universiti Kebangsaan Malaysia, 2000.
3. Abougalambou SSI. Assessment of the clinical treatment outcomes and direct medical costs among type 2 diabetes mellitus outpatients at the Hospital Universiti Sains Malaysia. PhD Thesis, Universiti Sains Malaysia, 2011.
4. Ahmad Ihsan AB. Prevalence of testosterone deficiency syndrome among men with type 2 diabetes in primary care clinic, University Malaya Medical Centre. M Fam Med Dissertation, University of Malaya, 2012.
5.
Ahmad Iskandar Zulkarnain J. Oculo-visual status of diabetics experiencing prolonged hyperglycaemia. [Status okular dan visual pesakit diabetes tanpa retinopati yang mengalami hiperglisemia berpanjangan]. Master Dissertation, Universiti Kebangsaan Malaysia, 2000.http://ptsldigital.ukm.my:8080/vital/access/services/Download/ukmvital:119/ABSTRACT
6. Ajay M. Vascular effects of flavonoids in hypertension and diabetes mellitus. PhD Thesis, University of Malaya, 2006.
7.
Akmal Naziah A. Factors influencing glycaemic control in older people with type 2 diabetes mellitus on oral hypoglycaemic therapy and attending a primary health care centre in Negeri Sembilan, Malaysia. MSc Dissertation, Universiti Putra Malaysia, 2011. http://psasir.upm.edu.my/19677/1/IG_2011_1.pdf8.
Al-anbari HSN. Evaluation of metformin usage in treatment of patients with type-2 diabetes mellitus inPenang General Hospital. MSc (Pharmacy) Dissertation, Universiti Sains Malaysia, 2008. http://eprints.usm.my/10179/1/EVALUATION_OF_METFORMIN_USAGE_IN.pdf
9. Al-Hamodi ZH. Genetic polymorphisms of plasminogen activator inhibitor-1 and tissue plasminogen activator in Malaysian subjects with type 2 diabetes. PhD Thesis, University of Malaya, 2012.
10. Al-Maweri, Sadeq Ali Ali Mohammed. Prevalence of oral mucosal lesions and the association between diabetes mellitus and oral precancerous lesions among Malay patients attending Hospital Universiti Sains Malaysia. MSc Dissertation, Universiti Sains Malaysia, 2009.
11. Alnajjar BOM. Computer-aided drug design of novel peroxisome proliferator-activated receptor gamma activators for the treatment of type 2 diabetes mellitus. PhD Thesis, Universiti Sains Malaysia, 2012. 12. al-Qazaz HKM. Assessment of knowledge and adherence to medication: a mixed methodology study
among patients with type-2 diabetes mellitus in Penang. PhD Thesis, Universiti Sains Malaysia, 2011. 13. Al-Zurfi BMN. Selected anthropometric parameters in relation to glycaemic control and associated factors
in Malay diabetic type 2 patients in HUSM. MSc Dissertation, Universiti Sains Malaysia, 2010. 14. Amrizal MN. A cost analysis of diabetes mellitus, pre-eclampsia and neonatal jaundice in Hospital
15. Chan HH. Salivary protein profiling for type 2 diabetes mellitus patients with and without periodontitis. M Dent Sc Dissertation, University of Malaya, 2013.
16. Choo AJ. Data analysis for diabetic patients. MSc Dissertation, Universiti Sains Malaysia, 2004.
17. Dharmendra H. The serological prevalence of Burkholderia pseudomallei infection among asymptomatic patients with diabetes mellitus who are attending the outpatient medical specialist clinic in University Malaya Medical Centre. Dissertation, University of Malaya, 2001.
18.
Eid Mohammad AM. Factors affecting diabetes control and dyslipidaemia among type 2 diabetes mellitus patients in Hospital Universiti Sains Malaysia. MSc Dissertation, Universiti Sains Malaysia,2003.http://eprints.usm.my/5569/1/Kaewalan_Diabetes_Dan_Dyslipidaemia.pdf
19.
Elhadi IE. Identification of factors affecting blood pressure control in patients admitted with hypertension in Penang General Hospital. Master of Science (Pharmacy), Universiti Sains Malaysia, 2007.http://eprints.usm.my/9650/1/IDENTIFICATION_OF_FACTORS_AFFECTING_BLOOD_PRESSURE_CONTROL_I N_PATIENTS_ADMITTED_WITH_HYPERTENSION_IN_PENANG_GENERAL_HOSPITAL.pdf.
20. Habshoh H. Prevalence of depression and associated factors in type 2 diabetes mellitus patients attending outpatient clinic Pendang Health Centre, Kedah Darulaman. M Fam Med Dissertation, Universiti
Kebangsaan Malaysia, 2000.
21. Haryati H. A study on glycemic control among insulin-treated type 2 diabetes patients attending diabetes centre, HUSM, Kelantan. MSc Dissertation, Universiti Sains Malaysia, 2009.
22.
Hasni I. Use of HbA1c in the diagnosis of type 2 diabetes mellitus in high risk group attending Klinik Rawatan Keluarga Hospital Universiti Sains Malaysia.MSc Dissertation, Universiti Sains Malaysia,2006.http://eprints.usm.my/8288/1/STUDIES_ON_DIABETIC_AND_PREDIABETIC_VASCULAR_DISEASE_AN D_THE_EFFECT_OF_SELECTED_THERAPEUTIC_MODALITIES_ON_ASSOCIATED_VASCULOPATHY.pdf;. 23. Hasniza H. Prevalence of falls and its associates factors among elderly diabetes attending Klinik Pakar
Perubatan and Klinik Rawatan Keluarga Hospital Universiti Sains Malaysia. MSc Dissertation, Universiti Sains Malaysia, 2009.
24.
Hazizi AS. Cardiovascular disease risk factors among type 2 diabetes and normal individuals. PhD Thesis, Universiti Putra Malaysia, 2010. http://psasir.upm.edu.my/6611/1/FPSK%28P%29_2006_2A.pdf 25. Hazlin M. Medication nonadherence among patients with type 2 diabetes mellitus attending a primarycare clinic. MFamMed Dissertation, University of Malaya, 2012.
26. Ho BK. The association of central obesity with hypercholesterolemia. MFamMed Dissertation, University of Malaya, 2000.
27. Ikhwan Sani M. Post operative morbidity and 3 years survival rate in diabetic and non diabetic patients undergoing coronary artery bypass grafting in Hospital Universiti Sains Malaysia. MSc Dissertation, Universiti Sains Malaysia, 2009.
28. Ishaq Aweis DM. Clinical outcomes and economic burden of patients having diabetes mellitus and tuberculosis in three hospitals in Malaysia. PhD Thesis, Universiti Sains Malaysia, 2011.
29.
Izzul Syazwan S. Initiation Of Insulin In Type 2 Diabetes Mellitus Patient. Bachelor of Pharmacy Dissertation, Universiti Teknologi MARA,2010.http://eprints.uitm.edu.my/2219/1/IZZUL_SYAZWAN_SHUIB_10_24.pdf.
30. Johan RI. Serum neurophil gelatinase-associated lipocalin (NGAL) characteristics in diabetic patients with renal impairment undergoing elective coronary angiogram in University Malaya Medical Centre. M Int Med Dissertation, University of Malaya, 2012.
31. Kamarul Imran M. The validation of the Malay translated audit of diabetes-dependent quality of life (ADDQOL). MSc Dissertation, Universiti Sains Malaysia, 2005.
32. Kareem Hamoodi H. Evaluation of type-2, diabetes mellitus among hepatitis B and C patients in Penang General Hospital, Malaysia. MSc Dissertation, Universiti Sains Malaysia, 2011.
33. Koo HC. A multiethnic study to determine the association of dietary intake and physical activity with plasma adiponectin concentrations among type 2 diabetis mellitus patients in Penang. MSc Dissertation, Universiti Sains Malaysia, 2012.
35. Lau WK. Development of cell-free assay system for the screening of PPAR-gamma ligands from natural products: in search for positive therapeutic agents for type 2 diabetes. PhD Thesis, Universiti Sains Malaysia, 2013.
36. Lee CS. The association of Fatty Acid Binding Protein polymorphism with obesity and type 2 diabetes mellitus in Malaysian subjects. MMedSc Dissertation, University of Malaya, 2010.
37. Loh BI. The association of glycemic index and dietary fiber with plasma adiponectin and leptin
concentrations among multiethnic patients with type 2 diabetes mellitus in Penang general hospital. MSc Dissertation, Universiti Sains Malaysia, 2013.
38. Luqman I. Urine bisphenol A level in patients with diabetes mellitus and metabolic syndrome. M Int Med Dissertation, University of Malaya, 2012.
39.
Mahmoud Sa’di MA. Economic, social and clinical evaluations of diabetes self management program at Universiti Sains Malaysia Health Center: comparison between structured and less structured educational programs. PhD Thesis, Universiti Sains Malaysia, 2008. http://eprints.usm.my/8954/1/ECONOMIC %2C_SOCIAL_AND_CLINICAL_EVALUATIONS_OF_DIABETES_SELF_MANAGEMENT_PROGRAM_AT_UNIVER SITI_SAINS_MALAYSIA_HEALTH_CENTER.pdf.40. Malik A. Influence of platelet rich plasma on osseointegration in controlled diabetic patients. MSc Dissertation, Universiti Sains Malaysia, 2008.
41. Mardhiah A, Chua, SS and Chan, SP. Common problems associated with the use of hypoglycaemic agents by diabetic patients. Dissertation, 2005.
42. Marilyn U. A cross sectional study on quality of life among non-insulin dependent diabetes mellitus patients in Sarikei, Sarawak. Master Dissertation, Universiti Kebangsaan Malaysia, 2007.
43. Mohamad Azfar Z. A comparison of quality of life based on Malay version audit of diabetes-dependent quality of life (Malay ADDQL) scores between type 2 diabetes mellitus patients on oral hypoglycemic agent only treatment versus insulin only or combined insulin and oral hypoglycemic agent treatment in HUSM Kelantan. MSc Dissertation, Universiti Sains Malaysia, 2011.
44. Mohamed Awad AAM. Pharmacoepidemiologic and direct medical cost evaluations of type 2 diabetes mellitus in Universiti Sains Malaysia. MSc Dissertation, Universiti Sains Malaysia, 2005.
45. Mohamed AAAE. The impact of compliance of the prescribers to the Malaysian consensus for type 2 diabetes mellitus management for hospitalized Penang hospital's patients and their self management. MSc Dissertation, Universiti Sains Malaysia, 2009.
46.
Mohd Dziehan M. Beliefs about medicine and medication adherence among malay patients with type 2 diabetes mellitus in primary health care. Master of Pharmacy Practice, Universiti Teknologi MARA, 2010.http://eprints.uitm.edu.my/7434/1/MOHD%20DZIEHAN%20MUSTAPA%2010_24.pdf 47. Moy FM. Nutritional status, knowledge, attitude and practice of type 2 diabetes patients. [Statuspemakanan dan tahap pengetahuan sikap dan amalan pesakit diabetes jenis 2]. Master Dissertation, Universiti Kebangsaan Malaysia, 2000.
48. Muhammad Huzaimi H. Association of TCF7L2 variants with type 2 diabetes mellitus susceptibility and treatment outcome in multi-ethnic Malaysian population. MMedSc Dissertation, University of Malaya, 2012.
49. Nik Sherina Haidi H. Continuity of care: Assessment of provider continuity and its impact on diabetes mellitus in family practice. MFamMed Dissertation, University of Malaya, 2000.
50. Noor Hasliza H. A study on the effect of oral hypoglycaemic agents on arterial stiffness among Malay patients with type 2 diabetes mellitus. MSc Dissertation, Universiti Sains Malaysia, 2006.
51. Noor Hasnita IM. Intrarenal resistive index (RI) in type 2 diabetes mellitus: correlation with creatinine clearance and association with urinary albumin excretion. MSc Dissertation, Universiti Sains Malaysia, 2009.
52. Nor Azwany Y. A study of the knowledge, attitude and practice and the effect of ramadan fasting on glycemic control and hydration status of type 2 diabetic patients in Hospital Universiti Sains Malaysia, Kubang Kerian, Kelantan. MSc Dissertation, Universiti Sains Malaysia, 2003.
54. Norazlin AK. A comparative study on economic burden between schizophrenia and diabetes mellitus in Malaysian secondary hospital. MSc Dissertation, Universiti Sains Malaysia, 2010.
55.
Norhidayah MJ. Diabetes diagnosis and monitoring web based using Decision Support System (DSS) approach. BSc Dissertation, Universiti Teknologi MARA, 2005.http://eprints.uitm.edu.my/10435/1/NORHIDAYAH%20BINTI%20MOHD%20JUSOH%2005_24.pdf.
56.
Nur Aqilah AR. Quality of life of type 2 diabetes mellitus (T2DM) patients in the endocrine clinic of HospitalPutrajaya. Bachelor of Pharmacy Dissertation, Universiti Teknologi MARA,
2010.http://eprints.uitm.edu.my/2248/1/NUR_AQILAH_ABDUL_RAHMAN_10_24.pdf.
57. Nurkhairizan K. Pendekatan penaakulan berasaskan perancangan menu pemakanan pesakit diabetes. Master Dissertation, Universiti Kebangsaan Malaysia, 2008.
58.
Nursazwina AS. Development of web based fuzzy expert system for disease diagnosis: diabetes diagnosis system. BSc Dissertation, Universiti Teknologi MARA,2006.http://eprints.uitm.edu.my/2219/1/IZZUL_SYAZWAN_SHUIB_10_24.pdf;;.
59. Nurul Akmar G. Risk of coronary heart disease in type 2 diabetes mellitus patients in Kelantan. MSc Dissertation, Universiti Sains Malaysia, 2011.
60. Nurul Azreen H. Depression and quality of life in patients with type 2 diabetes mellitus. MPM Dissertation, University of Malaya, 2011.
61.
Ooi CP. Application of a social cognitive theory model to analyse hypoglycaemic risk factors in older patients with type 2 diabetes in two rural primary healthcare clinics in Selangor, Malaysia. PhD Thesis, Universiti Putra Malaysia, 2010. http://psasir.upm.edu.my/27002/1/IG%202011%204R.pdf.62. Phang LL, Chua, SS and Chan, SP. Factors associated with medication adherence of type 2 diabetic patients and the role of healthcare providers. Dissertation, University of Malaya, 2006.
63. Rafidah G. Sistem pengkomputeran pengurusan diet bagi diabetes mellitus: pengenalpastian keperluan maklumat, pembangunan sistem dan evaluasi formatif. Master Dissertation, Universiti Kebangsaan Malaysia, 2005.
64. Raja Elina Afzan, Raja Ahmad. Determinants of exercise capacity in patients with uncomplicated type 2 diabetes mellitus. MMedSc Dissertation, University of Malaya, 2005.
65. Renukanth PCR. Effect of periodontal intervention on periodontal disease and type 2 diabetes mellitus. M Clin Dent (Periodontology) Dissertation, University of Malaya, 2011.
66. Rosediani M. Assessing glycaemic control: a randomized control trial between fasting and 2 hours postprandial blood glucose monitoring in type 2 diabetic patients attending Klinik Rawatan Keluarga, Universiti Sains Malaysia, Kelantan. MSc Dissertation, Universiti Sains Malaysia, 2005.
67. Rosmiza A. Prevalence of chronic kidney disease and its associated factors in type 2 diabetes mellitus. MFamMed Dissertation, University of Malaya, 2011.
68. Rozanah AR. Prevalence and associated risk factors of clostridium difficile infection in type 2 diabetes mellitus patients treated with antibiotics. MSc Dissertation, Universiti Sains Malaysia, 2010.
69. Salem SDH. Association of genetic polymorphism of hhex, igf2bp2 and slc30a8 with glutamic acid
decarboxylase antibody-negative diabetes and latent autoimmune diabetes in adults (LADA) in Malaysians. MMedSc Dissertation, University of Malaya, 2013.
70. Salmiah MA. Type 2 diabetes in Malaysia: perspectives of Malay patients and their health care professionals. PhD Thesis, University of Nottingham, 2006.
71. Samitah Z. Studies to determine the prevalence of candidate gene polymorphism and their association with arterial stiffness in diabetes mellitus among Malays. MSc Dissertation, Universiti Sains Malaysia, 2007.
72.
Sayeeda R. Studies on diabetic and prediabetic vascular disease and the effect of selected therapeutic modalities on associated vasculopathy. PhD Thesis, Universiti Sains Malaysia,2006.http://eprints.usm.my/8288/1/STUDIES_ON_DIABETIC_AND_PREDIABETIC_VASCULAR_DISEASE_AN D_THE_EFFECT_OF_SELECTED_THERAPEUTIC_MODALITIES_ON_ASSOCIATED_VASCULOPATHY.pdf.
73.
Sharifah Izwan TO. Polymorphism of beta3-adrenergic receptor, leptin receptor, glucocorticoid receptor2010.http://eprints.usm.my/9776/1/POLIMORFISMA_GEN_RESEPTOR_%CE%B23-ADRENERGIK %2C_GEN_RESEPTOR_LEPTIN%2C_GEN_RESEPTOR_GLUKOKORTIKOID_DAN_GEN_FAKTOR.pdf. 74. Shori AB. Inhibitory potential of Azadirchta indica-enriched yogurt against key enzymes linked to type-2
diabetes and hypertension. MSc Dissertation, University of Malaya, 2009.
75. Shubashini G. Pharmaceutical care for patients with tuberculosis and diabetes mellitus in Malaysia : a complex intervention. PhD Thesis, University of Nottingham, 2012.
76.
Sim SK. Oxidative dna damage in leukocytes and its association with metabolic control in diabetic patients with and without microalbuminuria. MSc Dissertation, Universiti Putra Malaysia,2001.http://psasir.upm.edu.my/11220/1/FPSK_M_2001_8_A.pdf.
77. Siti Rafiaah I. Prevalence of glucose intolerance and factors that influence it among pregnant women with and without risk at Antenatal Clinic, HUKM. Dissertation, Universiti Kebangsaan Malaysia, 2000.
78. Sudzilla N. Antiproteinuric effect of Rasilez (aliskiren) in hypertensive/normotensive type 2 diabetes added on to ACEI base treatment. MMed Dissertation, Universiti Sains Malaysia, 2013.
79. Suhaimi MI. Erectile dysfunction among diabetic patients attending Diabetic Clinic, Klinik Kesihatan Bandar, Kota Bharu and Hospital Universiti Sains Malaysia, Kubang Kerian, Kelantan. Dissertation, Universiti Sains Malaysia, 2002.
80. Suhaiza S. The impact of structured healthy lifestyle programs among type 2 diabetic patients in Pasir Puteh, Kelantan: a controlled trial .MSc Dissertation, Universiti Sains Malaysia, 2001.
81. Sukhbir KJS. A study of glycaemic control and the associated factors among diabetic patients at the Sungai Dua Health Clinic Penang. Dissertation, Universiti Kebangsaan Malaysia, 2000.
82. Sulaila B. A study on the effects of Andrographis paniculata (hempedu bumi) on serum protein C, protein S activity and fasting blood glucose in patients with type 2 diabetes mellitus. MMed Dissertation, Universiti Sains Malaysia, 2011.
83. Suraya M. Factors associated with unawarness of correct FBG target among type 2 diabetes mellitus patients in Hospital Universiti Sains Malaysia. MMed Dissertation, Universiti Sains Malaysia, 2012.
84.
Tan MY. Self-care practices of adults with poorly controlled diabetes mellitus in Malaysia. Doctorate inNursing Thesis, University of Adelaide, 2009.
http://digital.library.adelaide.edu.au/dspace/bitstream/2440/57031/1/02whole.pdf.
85. Tan SF. Decline rate of kidney function in patients with type 2 diabetes mellitus and the associated factors -a 10-ye-ar retrospective cohort study. MF-amMed Dissert-ation, University of M-al-ay-a, 2012.
86.
Tengku Ahmad Damitri Al-Astani TD. Expression of apoptosis markers in the skin microvasculature of patients with diabetes mellitus type 2 at Hospital Universiti Sains Malaysia. MSc Dissertation (Pathology), Universiti Sains Malaysia,2008.http://eprints.usm.my/9891/1/EXPRESSION_OF_APOPTOSIS_MARKERS_IN_THE_SKIN_MICROVASCU LATURE_OF_PATIENTS_WITH_DIABETES_MELLITUS_TYPE_2_AT_HOSPITAL_UNIVERSITI_SAINS_MALAYSIA. pdf.
87. Tengku Norbanee TH. A study of microalbuminuria and associated factors in patients with type 2 diabetes mellitus in Hospital Universiti Sains Malaysia, Kelantan. MSc Dissertation, Universiti Sains Malaysia, 2003.
88.
Vasudevan R. Analysis of Genetic Polymorphisms as Risk Factors in Essential Hypertension and Type 2Diabetes Mellitus among Malaysians. PhD Thesis, Universiti Putra Malaysia, 2009. http://psasir.upm.edu.my/7122/.
89. Vithyatheri G. A system for diagnosing diabetic patients using rule-based reasoning. M Comp Sc Dissertation, University of Malaya, 2011.
90. Wan Syamimee WG. Combination therapy for optimum glycaemic control: a randomized open label trial comparing rosiglitazone with combination sulphonylureas and metformin tablets in type 2 diabetes mellitus. MSc Dissertation, Universiti Sains Malaysia, 2006.
91. Yusliza Azreen MY. A study on the effect of cabergoline in patients with type 2 diabetes mellitus and metabolic syndrome. MMed Dissertation, Universiti Sains Malaysia, 2013.
92. Zaki Ghaith NF. Evaluation of combined metformin-lovastatin therapy in the treatment of diabetic type 2 patients with dyslipidemia in Hospital Pulau Pinang. MSc Dissertation, Universiti Sains Malaysia, 2010. 93. Zukri MA. The quality of care and complications status among patients with 15 years history of diabetes
Reviews, Editorials, Commentaries
1.
Abdulameer SA, Syed Azhar SS, Mohd Azmi AH, et al. Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do? Patient Prefer Adherence 2012;6:435-48http://www.dovepress.com/osteoporosis-and-type-2-diabetes-mellitus-what-do-we-know-and-what-we--peer-reviewed-article-PPA
2.
Amudha K, Sivalal S, Ng SH. Social support in type II diabetes care: a case of too little, too late. Diabetes Metab Syndr Obes 2012;5:407-17http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514066
3. Anuar Zaini MZ. Where is Malaysia in the midst of the Asian epidemic of diabetes mellitus? Diabetes Res Clin Pract 2000;50 Suppl 2:S23-8
4. Balakumar P, Sundram K, Dhanaraj SA. Dapagliflozin: Glucuretic action and beyond. Pharmacol Res 2014;82:34-9
5. Chan JCN, Chan SP, Deerochanawong C, et al. Diabetic dyslipidaemia in Asian populations in the Western Pacific Region: what we know and don't know. Diabetes Res Clin Pract 2011;94(1):1-13
6.
Erejuwa OO, Siti Amrah S, Mohd Suhaimi AW. Honey--a novel antidiabetic agent. Int J Biol Sci 2012;8(6):913-34http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399220/pdf/ijbsv08p0913.pdf
7. Erejuwa OO, Siti Amrah S, Mohd Suhaimi AW. Oligosaccharides might contribute to the antidiabetic effect of honey: a review of the literature. Molecules 2011;17(1):248-66
8. Haghverdizadeh P, Haerian M, Haghverdizadeh P, et al. ABCC8 genetic variants and risk of diabetes mellitus. Gene 2014;545(2):198-204
9. Hanis HH, Morris MJ, Kavurma MM. On the TRAIL of obesity and diabetes. Trends Endocrinol Metab 2013;24(11):578-87
10. Jeyamalar R, Lopez EA, Rahajoe AU, et al. Women's cardiovascular health: perspectives from South-East Asia. Nat Rev Cardiol 2012;9(8):464-77
11. Kavitha N, De S, Kanagasabai S. Oral hypoglycemic agents in pregnancy: An update. J Obstet Gynaecol India 2013;63(2):82-7
12.
Khaled AA, Sekaran M, Ikram Shah I. N(epsilon)-(carboxymethyl)lysine and coronary atherosclerosis-associated low density lipoprotein abnormalities in type 2 diabetes: current status. J Clin Biochem Nutr 2009;44(1):14-27http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613495
13. Laitiff AA, Teoh SL, Das S. Wound healing in diabetes mellitus: traditional treatment modalities. Clin Ter. 2010;161(4):359-64
14. Liew AKC, Punnanithinont N, Lee YC, et al. Effect of non-surgical periodontal treatment on HbA1c: a meta-analysis of randomized controlled trials. Aust Dent J 2013;58(3):350-7
15.
Lock JH, Fong KC. Retinal laser photocoagulation. Med J Malaysia 2010;65(1):88,94; quiz 95 http://www.e-mjm.org/2010/v65n1/Retinal_Laser_Photocoagulation.pdf16.
Lye HS, Kuan CY, Ewe JA, et al. The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci 2009;10(9):3755-75http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769158
17.
Maimunah M, Mazza D. Preconception care of women with diabetes: a review of current guideline recommendations. BMC Womens Health 2010;10:5,6874-10-5http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834595
18.
Mafauzy M. Diabetes mellitus in Malaysia. Med J Malaysia 2006;61(4):397-8 http://www.e-mjm.org/2006/v61n4/Diabetes_Mellitus_Malaysia.pdf19.
Mustaffa E. Diabetes epidemic in Malaysia. Med J Malaysia 2004;59(3):295-6http://www.e-mjm.org/2004/v59n3/Diabetes.pdf
21.
Matough FA, Siti B B, Zariyantey AH, et al. The role of oxidative stress and antioxidants in diabetic complications. Sultan Qaboos Univ Med J 2012;12(1):5-18http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286717/pdf/squmj-12-5.pdf
22. Mu YM, Misra A, Adam JMF, et al. Managing diabetes in Asia: overcoming obstacles and the role of DPP-IV inhibitors. Diabetes Res Clin Pract 2012;95(2):179-88
23. Muhaya M. The eye in diabetes. Hosp Med 2003;64(11):673-6
24. Naing C, Mak JW, Wai N, et al. Diabetes and infections-hepatitis C: is there type 2 diabetes excess in hepatitis C infection? Curr Diab Rep 2013;13(3):428-34
25. Ng CJ, Liew SM, Vethakkan SR, et al. Patient‐adjusted versus health professional‐adjusted insulin dosing for type 2 diabetes mellitus. The Cochrane Library 2013;(6)
26.
Nik Ritza Kosai, Nik Mahmood. Is bariatic surgery the cure for diabetes mellitus? Medicine & health 2013;8(2):52-4http://www.medicineandhealthukm.com/system/files/article/2014/Editorial.pdf
27.
Ong HT, Cheah JS. Choice of antihypertensive drug in the diabetic patient. MedGenMed 2005;7(2):74 http://www.medscape.org/viewarticle/50254628.
Ooi CP, Loke SC. Colesevelam for type 2 diabetes mellitus: an abridged Cochrane review. Diabet Med 2014;31(1):2-14http://onlinelibrary.wiley.com/doi/10.1111/dme.12295/pdf
29. Ooi CP, Loke SC. Sweet potato for type 2 diabetes mellitus. Cochrane Database Syst Rev 2013;9:CD009128 30. Ooi CP, Loke SC. Colesevelam for type 2 diabetes mellitus. Cochrane Database Syst Rev 2012;12:CD009361 31. Ooi CP, Zaitun Y, Tengku Aizan H. Momordica charantia for type 2 diabetes mellitus. Cochrane Database
Syst Rev 2012;8:CD007845
32.
Ramadas A, Quek KF, Chan CK, et al. Web-based interventions for the management of type 2 diabetes mellitus: a systematic review of recent evidence. Int J Med Inform 2011;80(6):389-405http://www.ijmijournal.com/article/S1386-5056%2811%2900047-5/pdf
33. Sayeeda R, Tahminur R, Aziz Al-Shafi I, et al. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis. Diabetes Obes Metab 2007;9(6):767-80
34.
Sazlina SG, Browning C, Mohd Shajahan MY. Interventions to promote physical activity in older people with type 2 diabetes mellitus: a systematic review. Front Public Health 2013;1:71http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870318/pdf/fpubh-01-00071.pdf
35. Shafie O, Fatanah I, Noor Azah D. Diabetes program in Malaysia - current and future. NCD Malaysia 2004;3(2):6-12
36. Sheu WHH, Azhari R, Mithal A, et al. Addressing the burden of type 2 diabetes and cardiovascular disease through the management of postprandial hyperglycaemia: an Asian-Pacific perspective and expert recommendations. Diabetes Res Clin Pract 2011;92(3):312-21
37.
Subramanian K, Sekaran M, Qvist R, et al. F(2)-isoprostanes as novel biomarkers for type 2 diabetes: a review. J Clin Biochem Nutr 2009;45(1):1-8http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704321/pdf/jcbn-45-1.pdf
38.
Thent ZC, Das S, Henry LJ. Role of exercise in the management of diabetes mellitus: the global scenario. PLoS One 2013;8(11):e80436http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi %2F10.1371%2Fjournal.pone.0080436&representation=PDF
39.
Velayudhan M. Managing diabetes during the Muslim fasting month of Ramadan. Med J Malaysia 2012;67(3):353,4; quiz 355http://www.e-mjm.org/2012/v67n3/Diabetes.pdf
40.
Wong RSY. Extrinsic factors involved in the differentiation of stem cells into insulin-producing cells: an overview. Exp Diabetes Res 2011;2011:406182http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124109
41. Wong TW. Design of oral insulin delivery systems. J Drug Target 2010;18(2):79-92
43.
Yogarabindranath SN. Influence of diabetes mellitus and risk factors in activating latent tuberculosis infection: a case for targeted screening in Malaysia. Med J Malaysia 2012;67(5):467-72http://www.e-mjm.org/2012/v67n5/latent-tuberculosis-infection.pdf
44.
Zainal Ariff AR, Hamimah H, Bunyarit SS. Clinical patterns of oro-facial infections. Annals of Dentistry University of Malaya 2005;12(1):18-23http://ejum.fsktm.um.edu.my/ArticleInformation.aspx?ArticleID=372
45.
Zanariah H, Hamdy O, Chia YC, et al. Transcultural Diabetes Nutrition Algorithm: A Malaysian Application. Int J Endocrinol 2013;2013:679396http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872099
46. Zar CT, Das S. Potential effect of herbs on diabetic hypertension: alternative medicine treatment modalities. Clin Ter 2013;164(6):529-35
Original research
VARIOUS SETTINGS, EXCEPT PRIMARY CARE
1.
Abdul Hamid J, Azmi MT. Predictors of survival among end stage renal failure patients undergoing dialysis treatment in Pahang from 2000 TO 2004. Jurnal Kesihatan Masyarakat 2009;15(1):76-84http://journalarticle.ukm.my/4626/1/Vol15(1)-azimatun.pdf
2. Abdulameer SA, Syed Azhar SS, Mohd Azmi AH, et al. Psychometric properties of the Malay version of the Osteoporosis Health Belief Scale (OHBS-M) among type 2 diabetic patients. Int J Rheum Dis 2014;17(1):93-105
3. Abdulameer SA, Syed Azhar SS, Mohd Azmi AH, et al. Psychometric properties and osteoprotective behaviors among type 2 diabetic patients: osteoporosis self-efficacy scale Malay version (OSES-M). Osteoporos Int 2013;24(3):929-40
4. Abdulameer SA, Syed Azhar SS, Mohd Azmi AH, et al. Psychometric properties of Osteoporosis Knowledge Tool and self-management behaviours among Malaysian type 2 diabetic patients. J Community Health 2013;38(1):95-105
5. Abougalambou SSI, Abougalambou ASI. A study evaluating prevalence of hypertension and risk factors affecting on blood pressure control among type 2 diabetes patients attending teaching hospital in Malaysia. Diabetes Metab Syndr 2013;7(2):83-6
6. Abougalambou SSI, Abougalambou ASI, Syed Azhar SS, et al. Prevalence of hypertension, control of blood pressure and treatment in hypertensive with type 2 diabetes in Hospital University Sains Malaysia. Diabetes Metab Syndr 2011;5(3):115-9
7.
Abougalambou SSI, Mohd Azmi AH, Syed Azhar SS, et al. Prevalence of vascular complications among type 2 diabetes mellitus outpatients at teaching hospital in Malaysia. Journal of Diabetes & Metabolism 2011;2(1):1000115http://omicsonline.org/2155-6156/2155-6156-2-115.pdf
8. Abougalambou SSI, Mafauzy M, Syed Azhar SS, et al. Current clinical status and complications among type 2 diabetic patients in Universiti Sains Malaysia hospital. International Journal of Diabetes Mellitus
2010;2(3):184-8
9.
Abougalambou SSI, Syed Azhar SS, Syed Wasif G, et al. Evaluation of direct medical cost among outpatients of type 2 diabetes mellitus: cost analysis in teaching hospital of Malaysia. Folia Medica FacultatisMedicinae Universitatis Saraeviensis (Journal of Medical Faculty University of Sarajevo, Bosnia & Herzegovina) 2010;45(1):3-8
http://mf.unsa.ba/podaci/folia/Folia%20medica%2045-1.pdf
10. Adibah Hanim I, Rawa B, Hatta S, et al. Factor analysis study on sexual responses in women with type 2 diabetes mellitus. Compr Psychiatry 2014;55 Suppl 1:S34-7
11. Adibah Hanim I, Rawa B, Hatta S, et al. Orgasmic dysfunction among Malay diabetic women in Malaysia. Compr Psychiatry 2014;55 Suppl 1:S29-33
Med Sci 2005;12(1):13-9
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349408
13.
Albaroodi KAI, Syed Sulaiman SA, Awaisu A. Evaluation of the most commonly used anti-diabetic drugs at a hospital in northern part of Peninsular Malaysia. International Journal of Medical and Pharmaceutical Sciences 2013;3(6). http://www.scopemed.org/fulltextpdf.php?mno=3415614.
Al-Hamodi Z, Saif-Ali R, Ikram Shah I, et al. Effect of plasminogen activator inhibitor-1 and tissueplasminogen activator polymorphisms on susceptibility to type 2 diabetes in Malaysian subjects. J Biomed Biotechnol 2012;2012:234937
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3336151
15.
Al-Hamodi Z, Ikram Shah I, Saif-Ali R, et al. Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects. Cardiovasc Diabetol 2011;10:23,2840-10-23http://www.cardiab.com/content/pdf/1475-2840-10-23.pdf.
16.
Al-Hamodi ZH, Saif-Ali R, Ikram Shah I, et al. Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects. J Clin Biochem Nutr2012;50(3):184-9
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334369
17. Ali RM, Degenhardt R, Robaayah Z, et al. Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus. EuroIntervention 2011;7 Suppl K:K83-92
18.
Al-Maweri SAA, Noorliza Mastura I, Abdul Rashid I, et al. Prevalence of oral mucosal lesions in patients with type 2 diabetes attending Hospital Universiti Sains Malaysia. Malays J Med Sci 2013;20(4):39-46 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC377335119. Al-Qazaz HK, Mohd Azmi AH, Asrul Akmal S, et al. Perception and knowledge of patients with type 2 diabetes in Malaysia about their disease and medication: a qualitative study. Res Social Adm Pharm 2011;7(2):180-91
20.
Al-Qazaz HK, Sulaiman SA, Mohd Azmi AH, et al. Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes. Int J Clin Pharm 2011;33(6):1028-35http://www.researchgate.net/publication/51798593_Diabetes_knowledge_medication_adherence_and_g lycemic_control_among_patients_with_type_2_diabetes/file/79e41504b611ebef28.pdf.
21.
Al-Qazaz HK, Mohd Azmi AH, Asrul Akmal S, et al. The 14-item Michigan Diabetes Knowledge Test: translation and validation study of the Malaysian version. Practical Diabetes International 2010;27(6):238-41http://www.thecochranelibrary.com/userfiles/espdi/file/238_241_PDI_JA.pdf.
22.
Al-Qazaz HK, Mohd Azmi AH, Asrul AS, et al. The eight-item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian version. Diabetes Res Clin Pract 2010;90(2):216-21http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109726
23. Amudha K, Choy AM, Mohamed R. M, et al. Short-term effect of atorvastatin on endothelial function in healthy offspring of parents with type 2 diabetes mellitus. Cardiovasc Ther 2008;26(4):253-61
24. Amudha K, Chee KH, Tan KS, et al. Prevalence of peripheral artery disease in urban high-risk Malaysian patients. Int J Clin Pract 2003;57(5):369-72
25. Annemans L, Demarteau N, Hu S, et al. An Asian regional analysis of cost-effectiveness of early irbesartan treatment versus conventional antihypertensive, late amlodipine, and late irbesartan treatments in patients with type 2 diabetes, hypertension, and nephropathy. Value Health 2008;11(3):354-64 26. Aravind SR, Shaiful Bahari I, Balamurugan R, et al. Hypoglycemia in patients with type 2 diabetes from
India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study. Curr Med Res Opin 2012;28(8):1289-96
27. Aravind SR, Al Tayeb K, Shaiful Bahari I, et al. Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study. Curr Med Res Opin
28.
Asma A, Azmi MN, Mazita A, et al. A single blinded randomized controlled study of the effect of conventional oral hypoglycemic agents versus intensive short-term insulin therapy on pure tone audiometry in type II diabetes mellitus. Indian J Otolaryngol Head Neck Surg 2011;63(2):114-8 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102159/pdf/12070_2011_Article_132.pdf29.
Assila AH, Seak YS, Goh ZP, et al. What contributes to the progression of chronic kidney disease in type 2 diabetic patients? International Journal of Public Health Research 2011;1(1):40-7http://journalarticle.ukm.my/3343/1/vol%25201%2520no%25201%25202011_6.pdf
30. Aswany N, Ismail AA, Wan Mohamad WB, et al. Effect of Ramadan fasting on glycemic status of type 2 diabetic patients in Northern Malaysia. International Medical Journal (IIUM) 2003;2(2).
31.
Aye M, Malek S. Waist circumference and BMI cut-off points to predict risk factors for metabolic syndrome among outpatients in a district hospital. Singapore Med J 2012;53(8):545-50http://www.sma.org.sg/UploadedImg/files/SMJ/5308/5308a8.pdf
32. Azarisman Shah MS, Aszrin A, Marzuki AO, et al. Blood pressure control among diabetic hypertensives under cardiology follow-up at a regional hospital in rural Malaysia. Southeast Asian J Trop Med Public Health 2010;41(4):973-81
33.
Azidah AK, Hasniza H, Zunaina E. Prevalence of falls and its associated factors among elderly diabetes in a tertiary center, Malaysia. Curr Gerontol Geriatr Res 2012;2012:539073http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369479
34. Azidah AK, Hasniza H. Prevalence of falls in elderly men with diabetes in Diabetic Clinic Universiti Sains Malaysia Hospital, Malaysia. Journal of Men's Health 2011;8 Suppl 1:S91-3
35. Azizi A, Rafidah Hanim M, Tariq AR. Effects of irbesartan on beta-cell function and insulin sensitivity in hypertensive and hypertensive diabetic subjects. International Medical Journal (IIUM) 2005;4(1).
36.
Azura Dina M, Wong M, Norlela S, et al. Prevalence of sexual dysfunction among premenopausal womenwith and without type 2 diabetes mellitus. Journal of Endocrinology and Metabolism 2013;3(1):29-39 http://www.jmems.org/index.php/jmems/article/view/75/59
37.
Badariah A, Khalid AK, Quek KF, et al. Knowledge of diabetes and lifestyle behaviour amongst indigenous population in Peninsular Malaysia. Med J Malaysia 2013;68(4):309-14http://www.e-mjm.org/2013/v68n4/knowledge-of-diabetes.pdf
38.
Badariah A, Ramadas A, Quek KF. The development and validation of diabetes knowledge questionnaire for the Indigenous population in Malaysia. Med J Malaysia 2010;65(4):273-6http://www.e-mjm.org/2010/v65n4/Diabetes_Knowledge.pdf
39. Barakatun Nisak MY, Ruzita AT, Norimah AK, et al. Improvement of dietary quality with the aid of a low glycemic index diet in Asian patients with type 2 diabetes mellitus. J Am Coll Nutr 2010;29(3):161-70
40.
Barakatun Nisak MY, Ruzita AT, Norimah AK, et al. Acute effect of low and high glycemic index meals onpost-prandial glycemia and insulin responses in patients with type 2 diabetes mellitus. Malaysian Journal of Medicine and Health Sciences 2009;5(1):11-20
http://medic.upm.edu.my/images/stories/journal/VOL5NO1_JANUARY2009.pdf
41.
Barnett AH, Krentz AJ, Strojek K, et al. The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study). Diabetes Obes Metab2008;10(12):1239-47
https://www.cgsmedicare.com/jc/MDCorner/BGM/29.pdf
42.
Bauman A, Phongsavan P, Schoeppe S, et al. Noncommunicable disease risk factors and socioeconomic inequalities – what are the links? A multicountry analysis of noncommunicable disease surveillance data. Report to the WHO Regional Office for the Western Pacific.2010;http://www.wpro.who.int/publications/docs/WHOSESFINALforupload.pdf
43.
Bawazir A, Gharebaghi R, Hussein A, et al. Non-arteritic anterior ischaemic optic neuropathy in Malaysia: a 5 years review. Int J Ophthalmol 2011;4(3):272-444. Biswas R, Maniam J, Lee EWH, et al. User-driven health care: answering multidimensional information needs in individual patients utilizing post-EBM approaches: an operational model. J Eval Clin Pract 2008;14(5):750-60
45. Buranakitjaroen P, Mangklabruks A, Leungwattanakij S, et al. Efficacy and safety of sildenafil in Asian males with erectile dysfunction and cardiovascular risk. J Med Assoc Thai 2007;90(6):1100-8
46. Chan C, Robaayah Z, Upendra K, et al. A randomized comparison of sirolimus‐eluting versus bare metal stents in the treatment of diabetic patients with native coronary artery lesions: The DECODE study. Catheterization and Cardiovascular Interventions 2008;72(5):591-600
47.
Chan JCN, Wat NMS, So WY, et al. Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study. Diabetes Care2004;27(4):874-9
http://care.diabetesjournals.org/content/27/4/874.full.pdf
48. Chan SP, Ji LN, Nitiyanant W, et al. Hypoglycemic symptoms in patients with type 2 diabetes in Asia-Pacific-Real-life effectiveness and care patterns of diabetes management: the RECAP-DM study. Diabetes Res Clin Pract 2010;89(2):e30-2
49.
Chan HH, Zubaidah HAR, Jessie K, et al. Salivary proteins associated with periodontitis in patients with type 2 diabetes mellitus. Int J Mol Sci 2012;13(4):4642-54http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344237/pdf/ijms-13-04642.pdf
50. Chan WK, Tan ATB, Vethakkan SR, et al. Non-alcoholic fatty liver disease in diabetics--prevalence and predictive factors in a multiracial hospital clinic population in Malaysia. J Gastroenterol Hepatol 2013;28(8):1375-83
51.
Chee EK, Kwan MK, Khoo EH. Necrotizing fasciitis of the lower limb - a prospective study of prognostic factors affecting mortality. Malays Orthop J 2009;3(1):32-5http://www.morthoj.org/2009v3n1/Necrotizing_Fasciitis_lower_limb.pdf.
52. Chia YC, Srinivas P. Cardiovascular disease risk in a semirural community in Malaysia. Asia Pac J Public Health 2009;21(4):410-20
53. Chiam PTL, Abdullah F, Chow HK, et al. The ethnic characteristics and prevalence of diabetes mellitus, hypertension and hyperlipidaemia in patients who underwent coronary artery bypass grafting in Hospital Universiti Kebangsaan Malaysia. Med J Malaysia 2002;57(4):460-6
54.
Chin KH, Sathyasurya DR, Hazizi AS, et al. Effect of ethnicity, dietary intake and physical activity on plasma adiponectin concentrations among malaysian patients with type 2 diabetes mellitus. Int J Endocrinol Metab 2013;11(3):167-74http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860115
55. Chin SP, Liew CK, Tay SP, et al. Platelet non-responsiveness to dual antiplatelet therapy and relation to coronary disease among diabetes patients. Int J Cardiol 2007;118(3):418-20
56. Chin SP, Shahrin Tarmizi CA, How SH, et al. Do patients' understanding of diabetes and perception of control predict higher HbA1c and complications? International Medical Journal (IIUM) 2006;5(1)
57.
Chong VHT, Tan CT, Goh KJ, et al. Occupational exposure, age, diabetes mellitus and outcome of acuteNipah encephalitis. Neurology Journal of Southeast Asia 2001;6:7-11 http://www.neurology-asia.org/articles/20011_007.pdf
58. Chong YB, Keng TC, Tan LP, et al. Clinical predictors of non-diabetic renal disease and role of renal biopsy in diabetic patients with renal involvement: a single centre review. Ren Fail 2012;34(3):323-8
59. Choo KE, Lau KB, Davis WA, et al. Cardiovascular risk factors in pre-pubertal Malays: effects of diabetic parentage. Diabetes Res Clin Pract 2007;76(1):119-25
60.
Choo M, Prakash K, Amir S, et al. Corneal changes in type II diabetes mellitus in Malaysia. Int J Ophthalmol 2010;3(3):234-6http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340640
61. Chuang LM, Soegondo S, Soewondo P, et al. Comparisons of the outcomes on control, type of
management and complications status in early onset and late onset type 2 diabetes in Asia. Diabetes Res Clin Pract 2006;71(2):146-55
63.
Cliffton A, Md. Mizanur R, Mohd Syafiq A. The relevant intervention strategies for improving medication adherence of diabetic patients. International Journal of Public Health Research 2013;3(1):236http://journalarticle.ukm.my/6132/1/vol_3_no_1_2013_31.pdf
64. Dhanjal TS, Lal M, Haynes R, et al. A comparison of cardiovascular risk factors among Indo-Asian and caucasian patients admitted with acute myocardial infarction in Kuala Lumpur, Malaysia and Birmingham, England. Int J Clin Pract 2001;55(10):665-8
65. Duong JK, Kumar SS, Kirkpatrick CM, et al. Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function. Clin
Pharmacokinet 2013;52(5):373-84
66.
Eid M, Mafauzy M, Faridah AR. Non-achievement of clinical targets in patients with type 2 diabetes mellitus. Med J Malaysia 2004;59(2):177-84http://www.e-mjm.org/2004/v59n2/Type_2_Diabetes_Mellitus.pdf
67.
Eid M, Mafauzy M, Faridah AR. Dyslipidaemic pattern of patients with type 2 diabetes mellitus. Malays J Med Sci 2004;11(1):44-51http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438150
68.
Eid M, Mafauzy M, Faridah A. Glycaemic control of type 2 diabetic patients on follow up at hospital universiti sains malaysia. Malays J Med Sci 2003;10(2):40-9http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561886
69. Eid M, Mafauzy M, Faridah AR. Dyslipidaemia In patients with type 2 diabetes mellitus. Journal of the ASEAN Federation of Endocrine Societies 2003;21(1/2):44-54.
70.
Elfatih IE, Abdul Razak M, Mohamed Izham MI, et al. A survey of tuberculosis cases in Penang Hospital: preliminary findings. Malaysian Journal of Pharmaceutical Sciences 2004;2(2):1-8http://myais.fsktm.um.edu.my/6805/1/a_survey_vol2_no2_(1-8)2004.PDF; http://www.pha.usm.my/pharmacy/Webpage%20journal/abstract/2.2-1.pdf
71. Eppens MC, Craig ME, Jones TW, et al. Type 2 diabetes in youth from the Western Pacific region: glycaemic control, diabetes care and complications. Curr Med Res Opin 2006;22(5):1013-20
72. ESRD Incidence Study Group, Stewart JH, McCredie MR, et al. Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002. Nephrol Dial Transplant 2006;21(8):2178-83
73. Etemad A, Ramachandran V, Pishva SR, et al. Analysis of Gln223Agr polymorphism of Leptin Receptor Gene in type II diabetic mellitus subjects among Malaysians. Int J Mol Sci 2013;14(9):19230-44 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794830
74.
Foo SH, Chan SP, Shaiful Bahari I, et al. Insulin resistance is the predominant pathophysiologic feature of hyperglycemia in newly diagnosed overweight and obese type 2 diabetes mellitus in two university hospitals in Malaysia. Journal of the ASEAN Federation of Endocrine Societies 2012;26(2):143-9http://www.asean-endocrinejournal.org/images/ISSUE2/oa-insulin%20resistance%20-%20malaysia.pdf 75. Foo SM, Wong HS, Zaki Morad MZ. Risk factors and incidence of posttransplant diabetes mellitus in renal
transplant recipients. Transplant Proc 2004;36(7):2139-40
76. Fuziah MZ, Hong JY, Zanariah H, et al. A national database on children and adolescent with diabetes (e-DiCARE): results from April 2006 to June 2007. Med J Malaysia 2008;63 Suppl C:37-40
77.
G. R. Letchuman R, Wan Nazaimoon WM, Wan Mohamad WB, et al. Prevalence of diabetes in the Malaysian National Health Morbidity Survey III 2006. Med J Malaysia 2010;65(3):180-6http://www.e-mjm.org/2010/v65n3/Diabetes.pdf
78. Ghani RA, Bin Yaakob I, Wahab NA, et al. The influence of fenofibrate on lipid profile, endothelial dysfunction, and inflammatory markers in type 2 diabetes mellitus patients with typical and mixed dyslipidemia. J Clin Lipidol 2013;7(5):446-53
79.
Gillani SW, Syed Azhar SS, Sari YO, et al. Perceived Stress Scale psychometric validation for Malaysian diabetic patients. British Journal of Pharmaceutical Research 2011;1(4):156-6380.
Gillani SW, Syed Azhar SS, Suzana CV, et al. Applicability of pharmaceutical care in endocrine clinic of Hospital Penang, Malaysia. Journal of Diabetes Research and Clinical Metabolism 2012;1(1):11 http://www.hoajonline.com/journals/pdf/2050-0866-1-11.pdf81. Go KW, Teo SM, Hasniza AH. Efficacy and safety of oral hypoglycaemic agents in the treatment of diabetes mellitus in patients with end stage renal failure on dialysis. Medical Practice Hospital Ipoh 2003;6(2):5-8 82. Goldhaber-Fiebert JD, Li H, Ratanawijitrasin S, et al. Inpatient treatment of diabetic patients in Asia:
evidence from India, China, Thailand and Malaysia. Diabet Med 2010;27(1):101-8
83.
Hamidon B, Nabil I, Raymond AA. Risk factors and outcome of dysphagia after an acute ischaemic stroke. Med J Malaysia 2006;61(5):553-7http://www.e-mjm.org/2006/v61n5/Acute_Ischaemic_Stroke.pdf
84. Hamidon B, Raymond AA. The impact of diabetes mellitus on in-hospital stroke mortality. J Postgrad Med 2003;49(4):307,9; discussion 309-10
85.
Hamidon B, Raymond AA. Predictors of in-hospital mortality after an acute ischaemic stroke. Neurology Journal of Southeast Asia 2003;8:5-8http://www.neurology-asia.org/articles/20031_005.pdf
86.
Hanifullah K. A call to arms – clear the confusion. Journal of Endocrinology and Metabolism 2013;3(1):24-8 http://www.jmems.org/index.php/jmems/article/view/74/5887. Hapizah MN, Musilawati M, Yeo CK, et al. Type of diabetes and waist-hip ratio are important determinants of serum lipoprotein (a) levels in diabetic patients. Diabetes Res Clin Pract 2002;56(3):221-7
88. Hasan SS, Syed Imran A, Nadeem Irfan B, et al. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics. Complement Ther Clin Pract 2009;15(3):152-7
89. Hasan SS, Ahmadi K, Santigo R, et al. The validity of the menopause-specific quality of life questionnaire in women with type 2 diabetes. Climacteric 2013;.
90.
Hasnan J, Mohd Imran Y, Damitri TD, et al. Relationship between apoptotic markers (Bax and Bcl-2) and biochemical markers in type 2 diabetes mellitus. Singapore Med J 2010;51(1):50-5http://smj.sma.org.sg/5101/5101a7.pdf
91.
Hasniza ZH, Lee CL. Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia. BMC Public Health 2013;13:1192,2458-13-1192http://www.biomedcentral.com/content/pdf/1471-2458-13-1192.pdf
92.
Hasniza ZH, Wee HF. Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study. BMC Endocr Disord 2013;13:2,6823-13-2http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542270
93.
Hasniza ZH, Yeap SM, Rokiah P. Episodes of hypoglycemia and hyperglycemia during the use of sliding scale insulin in hospitalized diabetes patients. Asian Biomedicine 2007;1(3):307-11http://abm.digitaljournals.org/index.php/abm/article/viewFile/133/52
94.
Hasniza ZH, Tan G,Kuan Foong, Rokiah P, et al. Different characteristics of diabetic ketoacidosis between type 1 and type 2 diabetes patients in Malaysia. Asian Biomedicine 2009;3(2):201-5http://abm.digitaljournals.org/index.php/abm/article/viewFile/446/327
95.
Hasniza ZH, Ong CW, Rokiah P. Self-monitoring of blood glucose among type-2 diabetes patients in Malaysia. Asian Biomedicine 2008;2(4):335-40http://abm.digitaljournals.org/index.php/abm/article/viewFile/198/117
96. Hassan SA, Rahman RA, Huda N, et al. Hospital-acquired Clostridium difficile infection among patients with type 2 diabetes mellitus in acute medical wards. J R Coll Physicians Edinb 2013;43(2):103-7
97. Hayati AR, Cheah FC, Tan AE, et al. Insulin-like growth factor-1 receptor expression in the placentae of diabetic and normal pregnancies. Early Hum Dev 2007;83(1):41-6
98.
Hayati AR, Cheah FC, Yong JF, et al. The role of serum insulin-like growth factor I (IGF-I) in neonatal outcome. J Clin Pathol 2004;57(12):1299-301http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1770509
99.
Hazizi AS, Zaitun MY, Mirnalini K, et al. Glycaemic control, lipid profile, blood pressure and body weight status among diabetics in rural Malaysia. International Medical Journal (IIUM) 2007;8(2):21-8100.Hidayah NI, Che Muhaya M, Hanizah Y, et al. Risk factors for low vision amongst individuals aged 40 years and above in the subdistrict of Beranang, Hulu Langat, Selangor. International Medical Research Journal 2001;5(1):13-6
101.
Home PD, Latif ZA, Gonzalez-Galvez G, et al. The effectiveness and safety of beginning insulin aspart together with basal insulin in people with type 2 diabetes in non-Western nations: results from the A(1)chieve observational study. Diabetes Res Clin Pract 2013;101(3):326-32http://www.diabetesresearchclinicalpractice.com/article/S0168-8227(13)00231-3/pdf
102.Ibrahim SS, baougalambou ASI, Rahmawati F, et al. Prevalence and control of hypertension among diabetes patients in Hospital Universiti Sains Malaysia, Malaysia. Majalah Farmasi Indonesia 2010;21(2):121-8
103.
Ikram Shah I, Wan Nazaimoon WM, Wan Mohamad WB, et al. Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia. Diabet Med 2001;18(6):501-8http://umexpert.um.edu.my/file/publication/00000559_30514.pdf
104.Ikram Shah I, Wan Nazaimoon WM, Wan Mohamad WB, et al. Sociodemographic determinants of glycaemic control in young diabetic patients in peninsular Malaysia. Diabetes Res Clin Pract 2000;47(1):57-69
105.
Indran M, Rokiah P, Chan SP, et al. Alteration of lipid peroxidation and antioxidant enzymes in young Malaysian IDDM patients. Med J Malaysia 2004;59(2):166-70http://www.e-mjm.org/2004/v59n2/Lipid_Peroxidation_Antioxidant_Enzymes.pdf.
106.
Ismail MN, Chee WSS, Nawawi H, et al. Obesity in Malaysia. Obes Rev 2002;3(3):203-8 http://site.ppk.com.my/Clients/ppkcommy/obesity_and_metabolic_risk_in_asians.pdf107.
Jamsiah M, Zurainatul Irwani I, Sharifa Ezat WP, et al. Stress among diabetic mellitus patients with complication at Raja Perempuan Zainab II Hospital, Kota Bharu, Kelantan. Jurnal Kesihatan Masyarakat 2009;15(1):39-46http://journalarticle.ukm.my/4622/1/Vol15(1)-azimatun.pdf
108.
Juwita S, Suraya M, Nor Azwany Y. Awareness of correct blood glucose target among type 2 diabetic mellitus patient attending diabetic centre of tertiary hospital. International Journal of Collaborative Research on Internal Medicine & Public Health 2012;4(12):1923-31http://www.iomcworld.com/ijcrimph/files/v04-n12-07.pdf.
109.Kalra S, Plata-Que T, Kumar D, et al. Initiation with once-daily BIAsp 30 results in superior outcome compared to insulin glargine in Asians with type 2 diabetes inadequately controlled by oral anti-diabetic drugs. Diabetes Res Clin Pract 2010;88(3):282-8
110.Kamarul Imran M, Ismail AA, Naing L, et al. The reliability and validity of the Malay version of the 18-item audit of Diabetes Dependent Quality of Life (the Malay ADDQOL) questionnaire. Southeast Asian J Trop Med Public Health 2007;38(2):398-405
111.
Kee CC, Yusoff hF, Sumarni MG, et al. Optimal BMI cut-off values for predicting diabetes, hypertension and hypercholesterolaemia in a multi-ethnic population. Public Health Nutr 2013;16(3):453-9http://journals.cambridge.org/download.php?file=%2FPHN
%2FPHN16_03%2FS1368980012002911a.pdf&code=49f9a158f8ba297da22b52fd9ff5084a.
112.
Khaled AA, Sekaran M, Ikram Shah I. Role of N-(carboxymethyl)lysine in the development of ischemic heart disease in type 2 diabetes mellitus. J Clin Biochem Nutr 2007;41(2):97-105http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2170948
113.Khalid AK, Wan Nazaimoon WN. The spread of diabetes mellitus in South-East Asia. Journal of the ASEAN Federation of Endocrine Societies 2001;19(1):14-9
114.Koay CB, Mohd Zabri Affendi M, Moissinac K. Comparison of olfactory acuity in diabetic and non-diabetic patients and using Alcohol Sniff Olfactory Test (ASOT) and University of Pennsylvania Smell Identification Test (UPSIT). International Medical Research Journal 2000;4(1).
Malays J Nutr 2013;19(2):163-72
http://nutriweb.org.my/publications/mjn0019_2/2%20Hamid%20_418(edSP)(RV)SP.pdf
116.
Kulenthran A, Abdul Majeed N. Glycated haemoglobin is a good predictor of neonatalhypoglycaemia in pregnancies complicated by diabetes. Malays J Pathol 2011;33(1):21-4 http://www.mjpath.org.my/2011.1/Glycated_haemoglobin.pdf
117.Kuppusamy UR, Indran M, Rokiah P. Glycaemic control in relation to xanthine oxidase and antioxidant indices in Malaysian type 2 diabetes patients. Diabet Med 2005;22(10):1343-6
118.Kuppusamy UR, Indran M, Tsara A, et al. Comparison of oxidative damage in Malaysian end-stage renal disease patients with or without non-insulin-dependent diabetes mellitus. Clin Chim Acta 2005;351(1-2):197-201
119.
Lai PSM, Chua SS, Tan CH, et al. Validation of the diabetes, hypertension and hyperlipidemia (DHL) knowledge instrument in Malaysia. BMC Med Res Methodol 2012;12:18,2288-12-18http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352255
120.Lai SY, Yahaya H, Noorizan AA, et al. A comparison of knowledge of diabetes mellitus between patients with diabetes and healthy adults: a survey from north Malaysia. Patient Educ Couns 2007;69(1-3):47-54
121.
Lai LC. Prevention of type 2 diabetes. Malays J Pathol 2002;24(2):71-6http://www.mjpath.org.my/past_issue/MJP2002.2/Prevention%20of%20type%202%20Diabetes.pdf 122.Latiffah AL, Nor Afiah MZ, Nor Amalina E, et al. Prevalence of diseases among elderly admitted to a tertiary
hospital in Malaysia 2002. International Medical Journal (IIUM) 2006;5(1).
123.
Lau CH, Sekaran M. Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study. Cardiovasc Diabetol 2011;10(1):8http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036610/pdf
124.Lee PY, Lee YK, Khoo EM, et al. How do health care professionals assess patients when initiating insulin therapy? A qualitative study. Prim Care Diabetes 2014;8(1):49-55
125.Lee YK, Lee PY, Ng CJ. Tactics in counselling patients to start insulin. Diabet Med 2013;30(3):373-4
126.
Lee YK, Low WY, Ng CJ. Exploring patient values in medical decision making: a qualitative study.PLoS One 2013;8(11):e80051
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839918
127.
Lee YY, Tee MH, Zurkurnai Y, et al. Thrombolytic failure with streptokinase in acute myocardial infarction using electrocardiogram criteria. Singapore Med J 2008;49(4):304-10http://smj.sma.org.sg/4904/4904a5.pdf
128.Lee YK, Low WY, Lee PY, et al. Factors influencing decision-making role preferences: A qualitative study of Malaysian patients with type 2 diabetes during insulin initiation. Int J Nurs Pract 2014
129.Li YY, Wang XM, Lu XZ. KCNQ1 rs2237892 C-->T gene polymorphism and type 2 diabetes mellitus in the Asian population: a meta-analysis of 15,736 patients. J Cell Mol Med 2014;18(2):274-82
130.
Lim TO, Rugayah B, Maimunah AH. Familial aggregation and determinants of post challenge blood glucose in four ethnic populations. Med J Malaysia 2004;59(3):357-71http://www.e-mjm.org/2004/v59n3/Familial_Aggregation.pdf
131.
Lim TO, Rugayah B, Zaki Morad MZ, et al. Bimodality in blood glucose distribution: is it universal? Diabetes Care 2002;25(12):2212-7http://care.diabetesjournals.org/content/25/12/2212.full.pdf+html
132.
Lim TO, Ding LM, Zaki Morad MZ, et al. Clustering of hypertension, abnormal glucose tolerance, hypercholesterolaemia and obesity in Malaysian adult population. Med J Malaysia 2000;55(2):196-208 http://www.e-mjm.org/2000/v55n2/Hypertension.pdf133.
Lim PC, Lim SL, Oiyammaal C. Glycaemic control and cost analysis when changing from gliclazide co-administered with metformin to pre-combined glibenclamide-metformin tablets in type 2 diabetes mellitus. Med J Malaysia 2012;67(1):21-4134.
Lim SL, Soh KP, Kuppusamy UR. Effects of naringenin on lipogenesis, lipolysis and glucose uptake in rat adipocyte primary culture: a natural antidiabetic agent. Internet Journal of Alternative Medicine 2008;5(2). https://ispub.com/IJAM/5/2/11973135.Lim-Abrahan MA, Jain AB, Wan Mohamad WB, et al. Safety and effectiveness of biphasic insulin aspart 30 in type 2 diabetes: results from the ASEAN cohort of the A(1)chieve study. Diabetes Res Clin Pract 2013;100 Suppl 1:S3-9
136.Linjawi S, Radhakrishna S, Sari R, et al. The study of once- and twice-daily biphasic insulin aspart 30 (BIAsp 30) with sitagliptin, and twice-daily BIAsp 30 without sitagliptin, in patients with type 2 diabetes
uncontrolled on sitagliptin and metformin-The Sit2Mix trial. Prim Care Diabetes 2014
137.Lock LT, Tzanakakis ES. Scalable production of pancreatic islet progenitors for diabetes cell therapies. Med J Malaysia 2008;63 Suppl A:5-6
138.
Loh BI, Sathyasuryan DR, Hamid Jan JM. Plasma adiponectin concentrations are associated with dietary glycemic index in Malaysian patients with type 2 diabetes. Asia Pac J Clin Nutr 2013;22(2):241-8 http://apjcn.nhri.org.tw/server/APJCN/22/2/241.pdf139.
Loke SC, Rahim KF, Kanesvaran R, et al. A prospective cohort study on the effect of various risk factors on hypoglycaemia in diabetics who fast during Ramadan. Med J Malaysia 2010;65(1):3-6 http://www.e-mjm.org/2010/v65n1/Hypoglycaemia_in_Diabetics.pdf140.Loke SC, Jong M. Metabolic control in type 2 diabetes correlates weakly with patient adherence to oral hypoglycaemic treatment. Ann Acad Med Singapore 2008;37(1):15-20
.
141.Loo KW, Griffiths LR, Gan SH. A sweet promise among Malaysians: Diabetes in Malaysia. J Diabetes 2014;.
142.
Mafauzy M, Zanariah H, Chan SP. The status of diabetes control in Malaysia: results of DiabCare2008. Med J Malaysia 2011;66(3):175-81
http://www.e-mjm.org/2011/v66n3/Diabetes_Control.pdf
143.Mafauzy M, Diabcare-Asia 2003 Study Group. An audit on diabetes management in Asian patients treated by specialists: the Diabcare-Asia 1998 and 2003 studies. Curr Med Res Opin 2008;24(2):507-14
144.
Mafauzy M. Diabetes control and complications in public hospitals in Malaysia. Med J Malaysia 2006;61(4):477-83http://www.e-mjm.org/2006/v61n4/Diabetes_Control_Complications.pdf
145.
Mafauzy M, Winn T, Rampal L, et al. A prelimenary result of the cardiovascular risk factors intervention study (Pikom Study): diabetes mellitus, hypertension and their associated factors. Malays J Med Sci 2005;12(1):20-5http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349409
146.
Mafauzy M, Mokhtar N, Wan Mohamad WB. Hypertension and associated cardiovascular risk factors in Kelantan. Med J Malaysia 2003;58(4):556-64http://www.e-mjm.org/2003/v58n4/Hypertension.pdf
147.Mafauzy M. Repaglinide versus glibenclamide treatment of Type 2 diabetes during Ramadan fasting. Diabetes Res Clin Pract 2002;58(1):45-53
148.
Marre M, Shaw J, Brandle M, et al. Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with type 2 diabetes (LEAD-1 SU). Diabet Med2009;26(3):268-78
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871176
149.Mastura I, Zanariah H, Fatanah I, et al. An Audit of Diabetes Control and Management (ADCM). Med J Malaysia 2008;63 Suppl C:76-7
150.Mastura I. Core competencies in diabetes care: educating health professionals as diabetes educators. NCD Malaysia 2005;4(2):2-3
151.
Md Yazid J, Fuziah MZ, Hadhrami M, et al. Reliability and validity of the Malay translated version of diabetes quality of life for youth questionnaire. Malaysian Family Physician 2013;8(1):12-9152.
Md Yazid J, Fuziah MZ, Hong JYH, et al. Reliability and validity of the revised summary of diabetes self-care activities (SDSCA) for Malaysian children and adolescents. Malaysian Family Physician2012;7(2&3):10-20
http://www.e-mfp.org/old/2012v7n2_3/Diabetes-Self-Care-Activities.pdf
153.
Minas H, Ruzanna ZZ, Marhani M, et al. Attitudes of Malaysian general hospital staff towards patients with mental illness and diabetes. BMC Public Health 2011;11:317,2458-11-317http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112131
154.
Mohamed EAH, Mohammad Jamshed AS, Ang LF, et al. Potent glucosidase and alpha-amylase inhibitory activities of standardized 50% ethanolic extracts and sinensetin from Orthosiphon stamineus Benth as anti-diabetic mechanism. BMC Complement Altern Med 2012;12:176,6882-12-176 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533584/pdf/1472-6882-12-176.pdf155.Mohammad Yousuf R, Humairah-Cheung AS. A diabetic patient with sudden periorbital swelling and proptosis. International Medical Journal (IIUM) 2003;2(2).
156.Mohammad Yousuf R, Fauzi ARM, How SH, et al. Metabolic changes during Ramadan fasting in normal people and diabetic patients. International Medical Journal (IIUM) 2003;2(2).
157.Mohd Amin Bujang, Puzziawati Abdul Ghani, Nur Amirah Zolkepali, Sharmini Selvarajah and Jamaiyah Haniff. A comparison between convenience sampling versus systematic sampling in getting the true parameter in a population: Explore from a clinical database: The Audit Diabetes Control Management (ADCM) registry in 2009International Conference on Statistics in Science, Business, and Engineering (ICSSBE) 2012201210-12 Sept;LangkawiIEEE;2012.
158.
Moy FM, Awang Bulgiba AM. The modified NCEP ATP III criteria maybe better than the IDF criteria in diagnosing Metabolic Syndrome among Malays in Kuala Lumpur. BMC Public Health 2010;10:678,2458-10-678http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989964
159.
Moy FM, Hoe VCW, Tan CPL, et al. Cardiovascular risks among shift and non-shift workers in a public medical centre in Kuala Lumpur. JUMMEC 2010;13(1):45-9http://jummec.um.edu.my/filebank/published_article/3155/JUMMEC%202010%2013(1)%2045-49.pdf
160.
Moy FM, Atiya AS, Wong ML. The results of a worksite health promotion programme in KualaLumpur, Malaysia. Health Promot Int 2006;21(4):301-10 http://heapro.oxfordjournals.org/content/21/4/301.full.pdf
161.
Muhammad RA H, Subhada PP, Ng PP, et al. Incidence, risk factors and clinical epidemiology of melioidosis: a complex socio-ecological emerging infectious disease in the Alor Setar region of Kedah, Malaysia. BMC Infect Dis 2010;10:302,2334-10-302http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975659
162.
Muhammad K, Al-Jamal HAN, Narazah MY. Association of ABO blood groups with diabetes mellitus. Libyan J Med 2010;5http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071167163.
Nadzimah MN, Thevarajah M, Chew YY. Hemoglobin variants detected by hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements. Int J Diabetes Dev Ctries 2010;30(2):86-90 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878696164.
Naing C, Mak JW, Syed Imran A, et al. Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis. World J Gastroenterol 2012;18(14):1642-51http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325531/pdf/WJG-18-1642.pdf.
165.Nawawi H, Sazali BS, Kamaruzaman BH, et al. Effect of ambient temperature on analytical and clinical performance of a blood glucose monitoring system: Omnitest Sensor glucose meter. Ann Clin Biochem 2001;38(Pt 6):676-83
166.Nazratun N, Mahmood AA, Kuppusamy UR, et al. Diabetes mellitus exacerbates advanced glycation end product accumulation in the veins of end-stage renal failure patients. Vasc Med 2006;11(4):245-50 167.Nazri M, Suhairi I, Wan Zaidah A, et al. Add-on rosiglitazone therapy improves plasminogen activity and
